PubMed

Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.

Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA.

Diabetes Metab. 2009 Nov;35(5):385-91. Epub 2009 Aug 7.PMID: 19665415 [PubMed - in process]Related articles

How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey.

Mosnier-Pudar H, Hochberg G, Eschwege E, Virally ML, Halimi S, Guillausseau PJ, Peixoto O, Touboul C, Dubois C, Dejager S.

Diabetes Metab. 2009 Jun;35(3):220-7. Epub 2009 Mar 19.PMID: 19303338 [PubMed - indexed for MEDLINE]Related articles

Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study.

Bringer J, Fontaine P, Detournay B, Nachit-Ouinekh F, Brami G, Eschwege E.

Diabetes Metab. 2009 Feb;35(1):25-31. Epub 2008 Nov 28.PMID: 19046913 [PubMed - indexed for MEDLINE]Related articles

Comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes: assessment of detemir administration in a progressive treat-to-target trial (ADAPT).

Le Floch JP, Lévy M, Mosnier-Pudar H, Nobels F, Laroche S, Gonbert S, Eschwege E, Fontaine P; Assessment of Detemir Administration in Progressive Treat-to-Target Trial (ADAPT) Study Group.

Diabetes Care. 2009 Jan;32(1):32-7. Epub 2008 Oct 22.PMID: 18945928 [PubMed - in process]Related articlesFree article

The Data from an Epidemiologic Study on the Insulin Resistance Syndrome Study: the change and the rate of change of the age-blood pressure relationship.

Safar ME, Lange C, Tichet J, Blacher J, Eschwège E, Balkau B; D.E.S.I.R. Study Group, France.

J Hypertens. 2008 Oct;26(10):1903-11.PMID: 18806613 [PubMed - indexed for MEDLINE]Related articles

Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain B, Czernichow S, Fumeron F, Froguel P, Vaxillaire M, Cauchi S, Ducimetière P, Eschwège E.

Diabetes Care. 2008 Oct;31(10):2056-61. Epub 2008 Aug 8.PMID: 18689695 [PubMed - indexed for MEDLINE]Related articlesFree article

Monitoring the obesity epidemic in France: the Obepi surveys 1997-2006.

Charles MA, Eschwège E, Basdevant A.

Obesity (Silver Spring). 2008 Sep;16(9):2182-6.PMID: 18535547 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: the ENTRED study 2001.

Romon I, Fosse S, Eschwège E, Simon D, Weill A, Varroud-Vial M, Detournay B, Fagot-Campagna A.

Diabetes Metab. 2008 Apr;34(2):140-7. Epub 2008 Mar 4.PMID: 18304854 [PubMed - indexed for MEDLINE]Related articlesFree article

[One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study]

Slama G, Eschwège E, Bernard MH, Grimaldi A, Oppert JM, Pouchain D, Bégaud B; pour le groupe des investigateurs de l'étude Avantage.

Ann Endocrinol (Paris). 2008 Feb;69(1):36-46. Epub 2008 Feb 20. French. PMID: 18243155 [PubMed - indexed for MEDLINE]Related articles

French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors.

Marant C, Romon I, Fosse S, Weill A, Simon D, Eschwège E, Varroud-Vial M, Fagot-Campagna A.

Diabetes Metab. 2008 Feb;34(1):38-45.PMID: 18068386 [PubMed - indexed for MEDLINE]Related articlesFree article

A review of the metabolic syndrome.

Balkau B, Valensi P, Eschwège E, Slama G.

Diabetes Metab. 2007 Dec;33(6):405-13. Epub 2007 Nov 5. Review.PMID: 17981485 [PubMed - indexed for MEDLINE]Related articlesFree article

[Evaluation of a screening programme for diabetic retinopathy (DODIA study)]

Aubert JP, Massin P, Audran G, Ben Mehidi A, Bernit B, Bouée S, Bouhassira M, Bourovitch JC, Erginay A, Eschwege E, Jamet M, Marre M, Nougairède M, Tcherny-Lessenot S.

Rev Prat. 2007 Jun 15;57(11):1203-9. French. PMID: 17691264 [PubMed - indexed for MEDLINE]Related articles

Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.

Hillier TA, Fosse S, Balkau B, Simon D, Eschwège E, Fagot-Campagna A.

J Cardiometab Syndr. 2006 Fall;1(5):318-25.PMID: 17679788 [PubMed - indexed for MEDLINE]Related articles

Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.

André P, Balkau B, Vol S, Charles MA, Eschwège E; DESIR Study Group.

Diabetes Care. 2007 Sep;30(9):2355-61. Epub 2007 Jun 22.PMID: 17586745 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.

Maison P, Balkau B, Souberbielle JC, Cunin P, Vol S, Macquin-Mavier I, Eschwège E; D. E. S. I. R. Study Group.

Diabet Med. 2007 Sep;24(9):1012-8. Epub 2007 May 29.PMID: 17535291 [PubMed - indexed for MEDLINE]Related articles

Consequences of change in waist circumference on cardiometabolic risk factors over 9 years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Balkau B, Picard P, Vol S, Fezeu L, Eschwège E; DESIR Study Group.

Diabetes Care. 2007 Jul;30(7):1901-3. Epub 2007 Apr 27. No abstract available. PMID: 17468349 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidemiological data on postprandial glycaemia.

Balkau B, Eschwège E.

Diabetes Metab. 2006 Sep;32 Spec No2:2S5-9.PMID: 17375400 [PubMed - indexed for MEDLINE]Related articles

Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.

Bruckert E, Baccara-Dinet M, Eschwege E.

Diabet Med. 2007 Apr;24(4):388-91. Epub 2007 Feb 28.PMID: 17335463 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the "SYMFONIE" study.

Pannier B, Thomas F, Eschwège E, Bean K, Benetos A, Leocmach Y, Danchin N, Guize L.

Diabetes Metab. 2006 Nov;32(5 Pt 1):467-74.PMID: 17110902 [PubMed - indexed for MEDLINE]Related articlesFree article

Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

André P, Balkau B, Born C, Charles MA, Eschwège E; D.E.S.I.R. study group.

Diabetologia. 2006 Nov;49(11):2599-603. Epub 2006 Sep 13.PMID: 16969645 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

Diabetes Care. 2006 Jul;29(7):1619-25.PMID: 16801588 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 year.

Raccah D, Hanaire-Broutin H, Sert-Langeron C, Brin S, Chabrier G, Fontaine PM, Rodier M, Vaur L, Eschwege E.

Diabetes Metab. 2006 Jun;32(3):244-50.PMID: 16799401 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study.

Tapp RJ, Balkau B, Shaw JE, Valensi P, Cailleau M, Eschwege E; DESIR Study Group.

Atherosclerosis. 2007 Jan;190(1):84-9. Epub 2006 May 3.PMID: 16674960 [PubMed - indexed for MEDLINE]Related articles

Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort.

Hillier TA, Fagot-Campagna A, Eschwège E, Vol S, Cailleau M, Balkau B; D.E.S.I.R. Study group.

Int J Epidemiol. 2006 Feb;35(1):190-6. Epub 2005 Dec 22.PMID: 16373378 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschwège E.

Diabetes Metab. 2005 Dec;31(6):542-50.PMID: 16357802 [PubMed - indexed for MEDLINE]Related articlesFree article

The metabolic syndrome.

Balkau B, Eschwège E.

Lancet. 2005 Dec 3;366(9501):1921; author reply 1923-4. No abstract available. PMID: 16325688 [PubMed - indexed for MEDLINE]Related articles

Epidemiology and costs of diabetes treated with insulin in France.

Detournay B, Raccah D, Cadilhac M, Eschwège E.

Diabetes Metab. 2005 Jun;31(3 Pt 2):3-18.PMID: 16142041 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmologique du diabète) study.

Massin P, Aubert JP, Eschwege E, Erginay A, Bourovitch JC, BenMehidi A, Nougarède M, Bouée S, Fagnani F, Tcherny MS, Jamet M, Bouhassira M, Marre M.

Diabetes Metab. 2005 Apr;31(2):153-62.PMID: 15959421 [PubMed - indexed for MEDLINE]Related articlesFree article

[Metabolic syndrome: which définition(s) for which objective(s)?]

Eschwège E.

Ann Endocrinol (Paris). 2005 Apr;66(2 Pt 2):1S32-44. Review. French. PMID: 15959403 [PubMed - indexed for MEDLINE]Related articles

[Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat]

Vray M, Joubert JM, Eschwège E, Liard F, Fagnani F, Montestruc F, Fages S, Bégaud B.

Therapie. 2005 Jan-Feb;60(1):17-24. French. PMID: 15929469 [PubMed - indexed for MEDLINE]Related articles

[Methodology and quality control in EPIGRAM, a pharmacoepidemiological study of obesity in general practice]

Vray M, Joubert JM, Eschwège E, Liard F, Fagnani F, Commenges B, Steinberg G, Bégaud B.

Therapie. 2004 Nov-Dec;59(6):573-9. French. PMID: 15789817 [PubMed - indexed for MEDLINE]Related articles

Effects of orlistat on obesity-related diseases - a six-month randomized trial.

Guy-Grand B, Drouin P, Eschwège E, Gin H, Joubert JM, Valensi P.

Diabetes Obes Metab. 2004 Sep;6(5):375-83.PMID: 15287931 [PubMed - indexed for MEDLINE]Related articles

Estimation of the prevalence of orally treated diabetes in France using a pharmacoepidemiologic approach: comparison between 1981 and 1992.

Vauzelle-Kervroëdan F, Forhan A, Guillemot D, Sermet C, Maison P, Balkau B, Eschwège E.

Pharmacoepidemiol Drug Saf. 1999 Dec;8(7):519-22.PMID: 15073895 [PubMed]Related articles

The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study.

Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Tichet J, Eschwège E; D.E.S.I.R. Study Group.

Diabetes Metab. 2003 Nov;29(5):526-32.PMID: 14631330 [PubMed - indexed for MEDLINE]Related articlesFree article

[Proposed law on protection of personal rights concerning personal information. Position of the French National Civil Rights Commission (CCTIR)]

Bara C, Berr C, Blacher J, Bloch J, Bonaïti C, Calvez T, Delpech M, Epelboin S, Eschwege E, Falissard B, Leplege A, Mayaux MJ, Perez P, Piedbois P, Seror V; Comité Consultatif sur le Traitement de l'Information en matière de Recherche dans le domaine de la Santé.

Rev Epidemiol Sante Publique. 2003 Jun;51(3):364-67. French. No abstract available. PMID: 14506800 [PubMed - indexed for MEDLINE]Related articles

The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications.

Eschwège E.

Diabetes Metab. 2003 Sep;29(4 Pt 2):6S19-27. Review.PMID: 14502097 [PubMed - indexed for MEDLINE]Related articlesFree article

[Metabolic syndrome or insulin resistance syndrome. Recent epidemiological data]

Eschwège E, Balkau B.

Ann Endocrinol (Paris). 2003 Jun;64(3 Suppl):S32-6. Review. French. PMID: 12910057 [PubMed - indexed for MEDLINE]Related articles

[Compliance with hormone replacement therapy in menopausal women: results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy]

Serfaty D, de Reilhac P, Eschwege E, Ringa V, Blin P, Nandeuil A, Tavera C, Mathieu M.

Gynecol Obstet Fertil. 2003 Jun;31(6):525-33. French. PMID: 12865191 [PubMed - indexed for MEDLINE]Related articles

[Methodology and long-term follow-up of drug induced side effects in children (cancer, leukemia, AIDS, growth hormone)]

Hoog-Labouret N, Lassale C, Eschwege E; Giens XVII.

Therapie. 2002 Jul-Aug;57(4):322-8. French. PMID: 12422552 [PubMed - indexed for MEDLINE]Related articles

Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study.

Balkau B, Forhan A, Eschwège E.

Diabetologia. 2002 Sep;45(9):1224-30. Epub 2002 Jul 6.PMID: 12242454 [PubMed - indexed for MEDLINE]Related articles

[Ionizing radiation and hyperplasia of the intimal matrix: current data and perspectives]

Ducasse E, Cosset JM, Eschwege E, Puppinck P, Lartigau E.

J Mal Vasc. 2002 Jun;27(3):137-42. Review. French. PMID: 12232530 [PubMed - indexed for MEDLINE]Related articles

Evaluation of risk factors for development of complications in Type II diabetes in Europe.

Liebl A, Mata M, Eschwège E; ODE-2 Advisory Board.

Diabetologia. 2002 Jul;45(7):S23-8. Epub 2002 Jun 19.PMID: 12136408 [PubMed - indexed for MEDLINE]Related articles

Anthropometric estimates of muscle and fat mass in relation to cardiac and cancer mortality in men: the Paris Prospective Study.

Oppert JM, Charles MA, Thibult N, Guy-Grand B, Eschwège E, Ducimetière P.

Am J Clin Nutr. 2002 Jun;75(6):1107-13.PMID: 12036820 [PubMed - indexed for MEDLINE]Related articlesFree article

[Prevalence of obesity in adults in France: the situation in 2000 established from the OBEPI Study]

Charles MA, Basdevant A, Eschwege E.

Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 1):154-8. Review. French. No abstract available. PMID: 11994680 [PubMed - indexed for MEDLINE]Related articles

[Epidemiology of heart disease in diabetes]

Eschwège E, Guillanneuf MT.

Diabetes Metab. 2001 Nov;27(5 Pt 2):S7-11. Review. French. PMID: 11910984 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of clinical audit on the quality of care in patients with type 2 diabetes: results of the DIABEST pilot study.

Varroud-Vial M, Charpentier G, Vaur L, Attali JR, Balarac N, Cervantes P, Kleinebreil L, Levy-Marchal C, Preiss P, Weisselberg C, Eschwege E.

Diabetes Metab. 2001 Dec;27(6):666-74.PMID: 11852375 [PubMed - indexed for MEDLINE]Related articlesFree article

Trends in antihypertensive drug use among orally treated diabetic patients, in France between 1981 and 1992. Impact of guidelines and new drugs.

Maison P, Planchat-Fely P, Vauzelle-Kervroëdan F, Sermet C, Eschwège E.

Diabetes Metab. 2001 Dec;27(6):661-5.PMID: 11852374 [PubMed - indexed for MEDLINE]Related articlesFree article

[Vascular complications of diabetes: is there a glycemic threshold?]

Isnard F, Eschwège E.

Rev Prat. 2001 Oct 15;51(16):1759-64. French. PMID: 11795118 [PubMed - indexed for MEDLINE]Related articles

A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration.

Maison P, Mennen L, Sapinho D, Balkau B, Sigalas J, Chesnier MC, Eschwège E; D.E.S.I.R. Study Group.

Atherosclerosis. 2002 Jan;160(1):155-60.PMID: 11755933 [PubMed - indexed for MEDLINE]Related articles

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial.

Simon D, Charles MA, Lahlou N, Nahoul K, Oppert JM, Gouault-Heilmann M, Lemort N, Thibult N, Joubert E, Balkau B, Eschwege E.

Diabetes Care. 2001 Dec;24(12):2149-51. No abstract available. PMID: 11723098 [PubMed - indexed for MEDLINE]Related articlesFree article